Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products ...
+ investors. NASDAQ:AEZS. $1.96
People also ask
Is Aeterna Zentaris a good stock to buy?
Who are Aeterna Zentaris competitors?
What does Aeterna Zentaris do?
Who is the manufacturer of Macrilen?
SEC Filings - Aeterna Zentaris Inc. Common Stock (AEZS) - Nasdaq
www.nasdaq.com › ... › Stocks › AEZS
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Investor Relations. Ginette Beaudet Vallières. Investor Relations Coordinator. (418) 652-8525 ext. 265. gvallieres@aezsinc.com. Media Relations. Paul Burroughs.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
Find the latest Aeterna Zentaris Inc. (AEZS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Jun 17, 2022 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Aeterna Zentaris Inc. Common Stock (AEZS) Institutional Holdings
www.nasdaq.com › ... › Stocks › AEZS
Find the latest institutional holdings data for Aeterna Zentaris Inc. Common Stock (AEZS) including shareholders, ownership summaries, ...
Our common shares are listed for trading on the TSX under the trading symbol "AEZ" and on the NASDAQ under the trading symbol "AEZS." The Company's agent for ...
AEterna Zentaris Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View AEZS financial statements in full.